多発性骨髄腫におけるIRF4依存症
Arthur L Shaffer1, N C Tolga Emre, Laurence Lamy
1Metabolism Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
Nature
|June 24, 2008
まとめ
インターフェロン調節因子4 (IRF4) の阻害は多発性骨髄腫細胞に毒性があり,サブタイプに共通する脆弱性を明らかにします. この研究では,骨髄腫の進行を駆動する重要なIRF4-MYC自己調節回路を発見しました.
科学分野:
- 免疫学 免疫学とは
- 分子生物学は分子生物学である.
- 腫瘍学 腫瘍学
背景:
- インターフェロン調節因子4 (IRF4) は,リンパ球の活性化とプラズマ細胞の発達に不可欠です.
- 多発性骨髄腫は,複雑な分子異質性と治癒力のない治療法を持つプラズマ細胞悪性腫瘍です.
- 骨髄腫のサブタイプ全体に共通する分子経路をターゲットにすることは,新しい治療戦略の開発に不可欠です.
研究 の 目的:
- 多発性骨髄腫における新たな治療標的を,その抑制が骨髄腫細胞に有毒である遺伝子をスクリーニングすることによって識別する.
- ミエロマにおけるIRF4の役割の基礎となる分子メカニズムの解明,その標的遺伝子および規制ネットワークを含む.
- パンミエロマの治療戦略としてIRF4ネットワークをターゲットにする可能性を調査する.
主な方法:
- ミエロマ細胞系における重要な遺伝子を特定するための機能喪失RNA干渉ベースの遺伝子スクリーニング.
- 遺伝子発現のプロファイリングにより,グローバルな遺伝子発現の変化を分析します.
- 直接的なIRF4標的遺伝子を特定するための全ゲノムクロマチン免疫降水 (ChIP) 分析.
主要な成果:
- IRF4の阻害は,特定の腫瘍原動力に関係なく,多様な多発性骨髄腫細胞系において毒性を示した.
- MYCを含むIRF4標的遺伝子の広範なネットワークが特定され,B細胞と骨髄腫でIRF4によって直接調節されます.
- MYCがミエロマ細胞でIRF4を直接トランザクティベーションする相互の自己調節回路が発見された.
- 骨髄腫細胞は,正常なプラズマ細胞と活性化されたB細胞の遺伝子発現プログラムを統合する異常なIRF4調節ネットワークへの依存を示します.
結論:
- IRF4は多発性骨髄腫の重要な脆弱性であり,すべてのサブタイプに適用可能な潜在的な治療目標を提供します.
- 特定されたIRF4-MYC自己調節ループは,骨髄腫の病原性を駆動する重要な腫瘍学的メカニズムを表しています.
- この異常なIRF4の規制ネットワークをターゲットにすることで,新しい,広く効果的な多発性骨髄腫治療法が期待されます.
関連する概念動画
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
01:03Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...